Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Peter Wiklund

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Journal of Cellular and Molecular Medicine|September 25, 2016
Prostaglandin D<sub>2</sub> effects and DP<sub>1</sub> /DP<sub>2</sub> receptor distribution in guinea pig urinary bladder out-flow regionNa N Guan, Karl Svennersten, Petra J de Verdier, et al.
The Journal of Urology|November 22, 2011
Pad use and patient reported bother from urinary leakage after radical prostatectomyAnna Wallerstedt, Stefan Carlsson, Andreas E Nilsson, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 11, 2014
The (CCTTT)n microsatellite polymorphism in the NOS2 gene may influence lung cancer risk and long-term survival, especially in non-smokersCharlotta Ryk, Sai-Mei Hou, Göran Pershagen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2017
Effect of Comorbidity on Prostate Cancer-Specific Mortality: A Prospective Observational StudyPrabhakar Rajan, Prasanna Sooriakumaran, Tommy Nyberg, et al.
Journal of Endourology|December 1, 2010
ProMIS™ can serve as a da Vinci® simulator--a construct validity studyMartin N Jonsson, Mahmood Mahmood, Tomas Askerud, et al.
Redox Biology|August 24, 2015
Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genesCharlotta Ryk, Lotta Renström Koskela, Tomas Thiel, et al.
European Urology|April 19, 2017
Survival Among Men at High Risk of Disseminated Prostate Cancer Receiving Initial Locally Directed Radical Treatment or Initial Androgen Deprivation TherapyPrasanna Sooriakumaran, Tommy Nyberg, Olof Akre, et al.
World Journal of Urology|June 16, 2018
Intravesical BCG treatment causes a long-lasting reduction of recurrence and progression in patients with high-risk non-muscle-invasive bladder cancerTomas Thiel, Charlotta Ryk, Lotta Renström-Koskela, et al.
The Journal of Sexual Medicine|June 25, 2011
Orgasm-associated urinary incontinence and sexual life after radical prostatectomyAndreas E Nilsson, Stefan Carlsson, Eva Johansson, et al.
BJU International|May 21, 2011
Age at surgery, educational level and long-term urinary incontinence after radical prostatectomyAndreas E Nilsson, Martin C Schumacher, Eva Johansson, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Journal of Cellular and Molecular Medicine|September 25, 2016
Prostaglandin D<sub>2</sub> effects and DP<sub>1</sub> /DP<sub>2</sub> receptor distribution in guinea pig urinary bladder out-flow regionNa N Guan, Karl Svennersten, Petra J de Verdier, et al.
The Journal of Urology|November 22, 2011
Pad use and patient reported bother from urinary leakage after radical prostatectomyAnna Wallerstedt, Stefan Carlsson, Andreas E Nilsson, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 11, 2014
The (CCTTT)n microsatellite polymorphism in the NOS2 gene may influence lung cancer risk and long-term survival, especially in non-smokersCharlotta Ryk, Sai-Mei Hou, Göran Pershagen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2017
Effect of Comorbidity on Prostate Cancer-Specific Mortality: A Prospective Observational StudyPrabhakar Rajan, Prasanna Sooriakumaran, Tommy Nyberg, et al.
Journal of Endourology|December 1, 2010
ProMIS™ can serve as a da Vinci® simulator--a construct validity studyMartin N Jonsson, Mahmood Mahmood, Tomas Askerud, et al.
Redox Biology|August 24, 2015
Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genesCharlotta Ryk, Lotta Renström Koskela, Tomas Thiel, et al.
European Urology|April 19, 2017
Survival Among Men at High Risk of Disseminated Prostate Cancer Receiving Initial Locally Directed Radical Treatment or Initial Androgen Deprivation TherapyPrasanna Sooriakumaran, Tommy Nyberg, Olof Akre, et al.
World Journal of Urology|June 16, 2018
Intravesical BCG treatment causes a long-lasting reduction of recurrence and progression in patients with high-risk non-muscle-invasive bladder cancerTomas Thiel, Charlotta Ryk, Lotta Renström-Koskela, et al.
The Journal of Sexual Medicine|June 25, 2011
Orgasm-associated urinary incontinence and sexual life after radical prostatectomyAndreas E Nilsson, Stefan Carlsson, Eva Johansson, et al.
BJU International|May 21, 2011
Age at surgery, educational level and long-term urinary incontinence after radical prostatectomyAndreas E Nilsson, Martin C Schumacher, Eva Johansson, et al.
Pageof 8